Revolution Medicines, Inc. (RVMD) Financials

RVMD Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 2.3 billion 753.8 million
Dec. 31, 2025 2.4 billion 723.2 million
Sept. 30, 2025 2.3 billion 655.0 million
June 30, 2025 2.4 billion 564.2 million

RVMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -355.7 million 87.3 million
Dec. 31, 2025 -276.2 million 33.7 million
Sept. 30, 2025 -210.7 million 30.8 million
June 30, 2025 -229.2 million 28.8 million

RVMD Net Income

No data available :(

RVMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.9 billion 140.0 million -
Dec. 31, 2025 2.0 billion 142.2 million 158.7 million
Sept. 30, 2025 1.9 billion - 158.5 million
June 30, 2025 2.1 billion - 132.8 million

RVMD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 198.1 million
Dec. 31, 2025 190.1 million
Sept. 30, 2025 189.2 million
June 30, 2025 188.1 million

RVMD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.5 million 344.0 million 101.3 million -
Dec. 31, 2025 1.9 million 292.6 million 64.3 million -
Sept. 30, 2025 3.3 million 262.5 million 52.8 million -
June 30, 2025 7.5 million 224.1 million 40.6 million -

RVMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 4.5 million
Dec. 31, 2025 - 4.7 million
Sept. 30, 2025 - -
June 30, 2025 - 3.8 million

RVMD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

RVMD

Price: $153.87

52 week price:
34.00
166.50

Earnings Per Share: -7.11 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 856800

Market Capitalization: 32.2 billion

Links: